SHILPAMED

Pharmaceuticals

Shilpa Medicare Ltd.

NSE: SHILPAMEDBSE: 530549ISIN: INE790G01031

₹603.60

-9.75 · -1.59%

As of 23 Jul 2026

Open

₹609.00

High

₹624.40

Low

₹601.00

Prev Close

₹613.35

52W High

₹860.00

52W Low

₹259.50

Volume

4.83 L

Mkt Cap

₹5,909 Cr

Fundamentals

Valuation & profitability

Market Cap

₹5,909 Cr

P/E Ratio

204

EPS (TTM)

₹2.96

Book Value

₹208.00

Dividend Yield

ROCE

5.27%

ROE

1.72%

Sales Growth

Face Value

₹1.00

Key highlights

Auto-generated from live data

Trades at a P/E of 204, with a return on equity (ROE) of 1.72%.
SHILPAMED is trading above 3 of 5 of its key moving averages (10/20/50/100/200-DMA) — a bullish technical setup.
Year-to-date it is up 95.15%, and up 64.48% over the past year.
At ₹603.60 it sits about 57% of the way up its 52-week range (₹259.50–₹860.00).
Market capitalisation stands at ₹5,909 Cr.

Price chart

Daily candles + volume · SMA 20 / 50 / 200 · stored OHLC

Shareholding pattern

Shareholding data syncs daily.

Performance

Stock returns vs Nifty 50

10D

-0.41%

Nifty -0.02%

20D

+3.27%

Nifty -1.06%

50D

+22.08%

Nifty +3.65%

100D

+49.96%

Nifty -0.62%

200D

+94.68%

Nifty -8.45%

YTD

+95.15%

Nifty -8.11%

52W

+64.48%

Nifty -7.37%

Moving averages

Simple moving averages vs current price

3/5 above · Bullish

SMA 10-Day

₹626.79Below

SMA 20-Day

₹610.31Below

SMA 50-Day

₹555.73Above

SMA 100-Day

₹465.51Above

SMA 200-Day

₹406.10Above

Price ranges

Where the price sits in each window

10-Day range₹603.60

₹601.00₹650.00

20-Day range₹603.60

₹556.95₹650.00

50-Day range₹603.60

₹432.50₹650.00

200-Day range₹603.60

₹259.50₹784.00

YTD range₹603.60

₹259.50₹650.00

52-Week range₹603.60

₹259.50₹949.90

Technical signals

Unfilled gaps acting as support / resistance

Unfilled Gap Up On 03 Feb, 2026 : 294.75 ~ 289.45SUPPORT

Unfilled Gap Down On 03 Oct, 2025 : 407.70 ~ 756.10RESISTANCE

Unfilled Gap Up On 30 Jun, 2023 : 255.00 ~ 252.50SUPPORT

Annual financials

Revenue, profit & EPS by financial year

Year	Revenue	Net Profit	EPS	NPM
Mar 2023	₹248 Cr	₹57 Cr	₹6.59	22.98%
Mar 2022	₹357 Cr	₹141 Cr	₹16.24	39.5%
Mar 2021	₹830 Cr	₹184 Cr	₹22.62	22.17%
Mar 2020	₹908 Cr	₹156 Cr	₹19.15	17.18%
Mar 2020	₹908 Cr	₹156 Cr	₹19.15	17.18%
Mar 2019	₹733 Cr	₹112 Cr	₹13.77	15.28%
Mar 2019	₹733 Cr	₹112 Cr	₹13.77	15.28%
Mar 2018	₹789 Cr	₹105 Cr	₹12.91	13.31%
Mar 2017	₹779 Cr	₹108 Cr	₹13.43	13.86%
Mar 2016	₹719 Cr	₹104 Cr	₹13.34	14.46%
Mar 2015	₹614 Cr	₹74 Cr	₹9.45	12.05%
Mar 2014	₹571 Cr	₹76 Cr	₹10.19	13.31%

Peer comparison

Other companies in Pharmaceuticals

Company	P/E	Book Value	Sales Growth
SUNPHARMA SUN PHARMACEUTICAL INDUSTRIES LTD.	39.1	₹98.33	10.1%
MARKSANS MARKSANS PHARMA LTD.	23.8	₹11.85	5.8%
MOREPENLAB MOREPEN LABORATORIES LTD.	20.81	₹6.43	16.6%
NEULANDLAB NEULAND LABORATORIES LTD.	23.48	₹542.16	9.35%
GUFICBIO Gufic BioSciences Ltd.	24.16	₹10.85	20.41%
DIVISLAB DIVI'S LABORATORIES LTD.	41.01	₹266.77	9.47%
DRREDDY DR.REDDY'S LABORATORIES LTD.	19.73	₹852.69	1.07%
RPGLIFE RPG LIFE SCIENCES LTD.	17.14	₹105.02	5.73%
GLAND Gland Pharma Ltd	53.6	₹242.00	—
ZYDUSLIFE Zydus Lifesciences Ltd	8.23	₹166.00	5%
SMSPHARMA SMS PHARMACEUTICALS LTD.	9.58	₹42.07	-8.73%
CIPLA CIPLA LTD.	15.36	₹209.71	0.7%

Dividend history

Per share, by ex-date

Ex-Date: 19 Sept 2022₹1.10

Ex-Date: 20 Sept 2021₹1.10

Ex-Date: 16 Mar 2020₹1.10

Ex-Date: 12 Sept 2019₹1.00

Ex-Date: 01 Mar 2018₹0.70

Ex-Date: 21 Mar 2017₹0.60

Ex-Date: 28 Mar 2016₹0.60

Ex-Date: 16 Sept 2015₹1.10

Ex-Date: 11 Sept 2014₹1.00

Ex-Date: 16 Jul 2013₹1.30

Ex-Date: 17 Sept 2012₹0.90

Ex-Date: 15 Sept 2011₹0.80

Bulk & block deals

Recent large transactions

Date	Client	Type	Qty	Price
21 Oct 2022	NALINI DHIRAJLAL PAREKH	PURCHASE	8,35,000	₹330.70
21 Oct 2022	PIVOTAL BUSINESS MANAGERS LLP	SALE	18,40,000	₹330.68
21 Oct 2022	ARUN JAYANTILAL SHAH	PURCHASE	3,06,667	₹330.70
21 Oct 2022	BIMAL JASVANTLAL PAREKH	PURCHASE	3,70,000	₹330.70
21 Oct 2022	MALIKA BIMAL PAREKH	PURCHASE	3,03,333	₹330.70
21 Oct 2022	NALINI DHIRAJLAL PAREKH	PURCHASE	8,35,000	₹330.70
21 Oct 2022	PIVOTAL BUSINESS MANAGERS LLP	SALE	3,03,333	₹330.70
21 Oct 2022	PIVOTAL BUSINESS MANAGERS LLP	SALE	3,06,667	₹330.70
21 Oct 2022	PIVOTAL BUSINESS MANAGERS LLP	SALE	3,70,000	₹330.70
21 Oct 2022	PIVOTAL BUSINESS MANAGERS LLP	SALE	8,35,000	₹330.70
03 Jun 2021	INDIA OPPORTUNITIES GROWTH FUND LTD - PINEWOOD STRATEGY	PURCHASE	8,70,000	₹511.00
03 Jun 2021	TANO MAURITIUS INDIA FVCI II	SALE	30,00,000	₹511.08

Explore more

Pharmaceuticals sector

Sector peers & index performance

SHILPAMED news & filings

Latest corporate announcements

Top Gainers

Biggest NSE gainers today

Top Losers

Biggest NSE losers today

IPO Calendar

Open & upcoming IPOs

Stock Screener

Find more stocks like this

Fundamentals, financials & technicals sourced from niftytrader.in, cached and refreshed periodically.